Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Aarey Drugs & Pharmaceuticals Limited (NSE: AAREYDRUGS), ISIN INE198H01019 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
AAREYDRUGS last traded at ₹109.25 (+1.42%), with a 52-week range of ₹50.40 to ₹118.90 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 41.45%, FIIs 4.28%, DIIs 1.44%, mutual funds 0.00%.
EquiSense Score (ECS): 11/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.